VYNT
Vyant Bio Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Vyant Bio operates two wholly-owned subsidiaries, StemoniX and vivoPharm. The Company will immediately begin to execute on the integration of these two leading businesses, to converge human-powered scientific and technology-based systems and expertise with years of preclinical experience to de-risk and accelerate discovery and development of preclinical and clinical pipelines for biopharma partners as well as for the proprietary pipeline of the Company.
Market Cap: 1.63 Million
Primary Exchange: NASDAQ
Website: www.vyantbio.com
Shares Outstanding: 6.27 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.4616197302792558
Sector: Health Care and Social Assistance
Industry: Medical Laboratories
Ethical Flags
Longest drawdown: 52 trading days
From: 2023-02-28 To: 2023-05-12
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|